2013 BIO CEO - Participating Companies

  • Recommend
  • Tweet
  • Print
  • Email

Aastrom Biosciences, Inc
ACADIA Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc
Aduro Biotech
ADVENTRX Pharmaceuticals, Inc
Affymax, Inc
Agenus Inc.
Albany Molecular Research, Inc
Alkermes plc
Alnylam Pharmaceuticals, Inc
Anthera Pharmaceuticals, Inc
Antisense Therapeutics Limited
Applied Genetic Technologies Corporation
Apricus Biosciences, Inc.
Aradigm Corporation
Aratana Therapeutics, Inc
Arena Pharmaceuticals, Inc
Astex Pharmaceuticals, Inc.
AstraZeneca
Athersys, Inc
Atossa Genetics Inc.
biocrea
Biodelivery Sciences International, Inc.
BioLineRx, Ltd
Biotie Therapies Corp.
Blaise Group International
Bristol-Myers Squibb Company
Business Wire
Campbell Alliance
Cardium Therapeutics, Inc
Catabasis Pharmaceuticals, Inc
Catalyst Pharmaceutical Partners, Inc
CEL-SCI Corporation
Cell Therapeutics, Inc
Cellerant Therapeutics, Inc
Cellixe
Cempra Pharmaceuticals, Inc
Ceregene, Inc
ChemoCentryx, Inc
Chimerix, Inc
Cleveland BioLabs, Inc
CoLucid Pharmaceuticals, Inc
Cyclacel Pharmaceuticals, Inc
CytRx Corporation
DARA BioSciences, Inc.
DiaMedica Inc.
DURECT Corporation
EpiCept Corporation
Epirus Biopharmaceuticals, Inc.
Eternity Healthcare Inc.
Exelixis, Inc
Fate Therapeutics, Inc
FivePrime Therapeutics, Inc
Forest Laboratories, Inc
Forma Therapeutics, Inc
FreeMind Group, LLC
Furiex Pharmaceuticals
Galena Biopharma
Genfit Corporation
GenVec, Inc
GeoVax Labs, Inc
GlaxoSmithKline plc
GlobeImmune, Inc
GTx, Inc
Horizon Pharma, Inc
Hydra Biosciences, Inc
iCo Therapeutics, Inc
Idenix Pharmaceuticals, Inc
Idera Pharmaceuticals, Inc
Igenica, Inc
Immune Design Corporation
ImmunoCellular Therapeutics, Ltd
ImmunoGen, Inc
Immunovaccine Inc.
Inovio Pharmaceuticals, Inc
KaloBios Pharmaceuticals, Inc
KineMed, Inc
Kinex Pharmaceuticals
Lexicon Pharmaceuticals, Inc
Mdxhealth
MedPanel
Merck
Mersana Therapeutics, Inc
Mirna Therapeutics, Inc
NACD
Navidea Biopharmaceuticals
NeoStem, Inc
NewGen Therapeutics, Inc.
Newron Pharmaceuticals, SpA
NicOx, SA
NovaBay Pharmaceuticals, Inc
Novavax, Inc
Novelos Therapeutics, Inc.
NPS Pharmaceuticals, Inc
Nymox Pharmaceutical Corp
Ohr Pharmaceutical Inc
Oncogenex Pharmaceuticals, Inc
Oncolytics Biotech Inc.
OncoMed Pharmaceuticals, Inc
Onconova Therapeutics, Inc
OncoSec Medical Incorporated
Onyx Pharmaceuticals, Inc
Opexa Therapeutics
Oragenics, Inc
Orexigen Therapeutics, Inc
OXiGENE, Inc
Oxygen Biotherapeutics
Palatin Technologies, Inc
PDL BioPharma
Pfizer Inc
Polynoma LLC
POZEN, Inc
PRIAXON AG
Prima Biomed Gmbh
Promedior, Inc
ProMetic Life Sciences, Inc
ProQr Therapeutics BV
Prosensa Therapeutics
Protalix Biotherapeutics Inc.
Proteon Therapeutics
Provista Diagnostics, Inc.
pSivida Corp
Purdue Pharma LP
Q Therapeutics, Inc
Regado Biosciences, Inc
ReNeuron
Repros Therapeutics, Inc
Resverlogix Corporation
Retrophin
Rib-X Pharmaceuticals, Inc
Rigel Pharmaceuticals, Inc
Roth Healthcare
RXi Pharmaceuticals Corporation
SciClone Pharmaceuticals, Inc
Soligenix, Inc.
Stallergenes SA
StemCells, Inc
Stifel Nicolaus Weisel - Banking
Sucampo Pharmaceuticals, Inc
Sutro Biopharma, Inc
Syndax Pharmaceuticals, Inc
Synthetic Biologics
Targacept, Inc
Tekmira Pharmaceuticals Corp.
Tengion, Inc
Texas Heart Institute
TG Therapeutics Inc.
The Leukemia & Lymphoma  Society
The Michael J. Fox Foundation
The University of Chicago
Threshold Pharmaceuticals, Inc
Tiberend Strategic Advisors, Inc.
Tigenix Nv
Tobira Therapeutics, Inc
TONIX Pharmaceuticals, Inc
Transcept Pharmaceuticals, Inc
Transition Therapeutics, Inc
Tranzyme, Inc
Trevena, Inc.
uniQure BV
Venaxis, Inc.
Verastem
Zafgen Inc.
Zalicus Inc
ZIOPHARM Oncology, Inc
Zymeworks Inc

 

*As of 1/24/13